000 | 01519 a2200397 4500 | ||
---|---|---|---|
005 | 20250517014155.0 | ||
264 | 0 | _c20160104 | |
008 | 201601s 0 0 eng d | ||
022 | _a1613-6829 | ||
024 | 7 |
_a10.1002/smll.201402377 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Wei | |
245 | 0 | 0 |
_aOvercoming multiple drug resistance by spatial-temporal synchronization of epirubicin and pooled siRNAs. _h[electronic resource] |
260 |
_bSmall (Weinheim an der Bergstrasse, Germany) _cApr 2015 |
||
300 |
_a1775-81 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCalcium Phosphates _xchemistry |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aDrug Resistance, Multiple |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
650 | 0 | 4 | _aGene Silencing |
650 | 0 | 4 | _aHep G2 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNanocapsules _xadministration & dosage |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
650 | 0 | 4 |
_aRNA, Small Interfering _xadministration & dosage |
650 | 0 | 4 | _aSpatio-Temporal Analysis |
700 | 1 | _aLiu, Xueyao | |
700 | 1 | _aXiao, Yun | |
700 | 1 | _aTang, Ruikang | |
773 | 0 |
_tSmall (Weinheim an der Bergstrasse, Germany) _gvol. 11 _gno. 15 _gp. 1775-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/smll.201402377 _zAvailable from publisher's website |
999 |
_c24585108 _d24585108 |